KMO inhibition was also envisioned to counter the detrimental effects of repeated stress or excessive immune activation, which have been proposed to play key roles in depressive disorders by increasing 3-HK and quinolinic acid levels in the brain [61,62,63,64,65,66]. The gene discussed is KMO; the disease is depressive disorder.